-- 174,000-square-foot commercial GMP facility in Durham, NC for the manufacturing of ADVM-022, an intravitreal gene therapy in development for wet AMD and DME ---- Multiple production suites with total capacity of 4000L, with further expansion opportunities --

Read the original here:
Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *